» Articles » PMID: 35132674

Parental Motivations for and Adaptation to Trio-exome Sequencing in a Prospective Prenatal Testing Cohort: Beyond the Diagnosis

Overview
Journal Prenat Diagn
Publisher Wiley
Date 2022 Feb 8
PMID 35132674
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To understand motivations for and parental interpretation of results from trio-exome sequencing (ES) for fetal anomalies with a negative standard genetic diagnosis.

Methods: Analysis of an ongoing, prospective prenatal trio-ES study of pregnancies with ultrasound-identified congenital anomalies and lack of a standard genetic diagnosis. After determination of pregnancy disposition, participants completed questionnaires and a semi-structured interview pre- and post-sequencing. Interviews were analyzed using a constructivist grounded theory methodology to identify themes. Associations between themes and ES result were also examined.

Results: One hundred twenty-six trios have been sequenced. Of those, 45 (36%) resulted in fetal diagnosis. One hundred twenty-five women completed pre-sequencing surveys, and 91 women completed post-sequencing surveys. The main themes identified include (1) variable reasons to pursue ES, (2) limited expectations but high hopes from ES, (3) parental adaptation to uncertain results, (4) impact on personal health and reproduction, and (5) gratitude for the process.

Conclusion: Participants pursued ES for various reasons, most often to identify a diagnosis and guide reproduction. Post-sequencing, most participants described the process, their interpretation of results, and the impact of receiving the results. Less frequently, but of most concern, participants expressed anxiety about testing and implications for themselves, relationships, and other family members, thus identifying an area of high need for additional support among patients undergoing prenatal ES.

Citing Articles

Beyond the Diagnosis: Valuing Genome-Wide Sequencing for Rare Disease Diagnosis Using Contingent Valuation.

Abbott M, Ryan M, Hernandez R, Heidenreich S, Miedzybrodzka Z Appl Health Econ Health Policy. 2025; .

PMID: 40082384 DOI: 10.1007/s40258-025-00948-x.


Equity and timeliness as factors in the effectiveness of an ethical prenatal sequencing service: reflections from parents and professionals.

Peter M, Hill M, Fisher J, Daniel M, McInnes-Dean H, Mellis R Eur J Hum Genet. 2024; 33(3):360-367.

PMID: 39362995 PMC: 11894143. DOI: 10.1038/s41431-024-01700-0.


Access to prenatal exome sequencing for fetal malformations: A qualitative landscape analysis in the US.

Sahin-Hodoglugil N, Lianoglou B, Ackerman S, Sparks T, Norton M Prenat Diagn. 2023; 43(11):1394-1405.

PMID: 37752660 PMC: 10846391. DOI: 10.1002/pd.6444.


Diagnostic yield and psychological outcomes among women pursuing trio-exome sequencing: Do women with recurrent anomalous fetal phenotypes experience more negative psychological outcomes?.

Talati A, Gilmore K, Hardisty E, Lyerly A, Rini C, Vora N Prenat Diagn. 2023; 43(5):569-578.

PMID: 36690925 PMC: 10176200. DOI: 10.1002/pd.6318.


Implementation of Exome Sequencing in Prenatal Diagnosis and Impact on Genetic Counseling: The Polish Experience.

Kucinska-Chahwan A, Geremek M, Roszkowski T, Bijok J, Massalska D, Ciebiera M Genes (Basel). 2022; 13(5).

PMID: 35627109 PMC: 9140952. DOI: 10.3390/genes13050724.


References
1.
Fisher E, Pratt R, Esch R, Kocher M, Wilson K, Lee W . The role of race and ethnicity in views toward and participation in genetic studies and precision medicine research in the United States: A systematic review of qualitative and quantitative studies. Mol Genet Genomic Med. 2019; 8(2):e1099. PMC: 7005620. DOI: 10.1002/mgg3.1099. View

2.
Petrovski S, Aggarwal V, Giordano J, Stosic M, Wou K, Bier L . Whole-exome sequencing in the evaluation of fetal structural anomalies: a prospective cohort study. Lancet. 2019; 393(10173):758-767. DOI: 10.1016/S0140-6736(18)32042-7. View

3.
Wou K, Weitz T, McCormack C, Wynn J, Spiegel E, Giordano J . Parental perceptions of prenatal whole exome sequencing (PPPWES) study. Prenat Diagn. 2018; 38(11):801-811. DOI: 10.1002/pd.5332. View

4.
Best S, Wou K, Vora N, Van der Veyver I, Wapner R, Chitty L . Promises, pitfalls and practicalities of prenatal whole exome sequencing. Prenat Diagn. 2017; 38(1):10-19. PMC: 5745303. DOI: 10.1002/pd.5102. View

5.
Vora N, Gilmore K, Brandt A, Gustafson C, Strande N, Ramkissoon L . An approach to integrating exome sequencing for fetal structural anomalies into clinical practice. Genet Med. 2020; 22(5):954-961. PMC: 7205580. DOI: 10.1038/s41436-020-0750-4. View